Volume 14, Number 6—June 2008
Perspective
Major Issues and Challenges of Influenza Pandemic Preparedness in Developing Countries
Hitoshi Oshitani*
, Taro Kamigaki*, and Akira Suzuki*
, Taro Kamigaki*, and Akira Suzuki*Table 1
Cost of purchasing oseltamivir to cover 25% of population with regard to total health expenditure in countries with different economic status*
| Category of country | Average GNP, per capita† | Average annual health expenditure, per capita† | Cost of 1 treatment course of oseltamivir, % annual health expenditure |
|---|---|---|---|
| High income | 30,168 | 3,376 | 0.11 |
| Upper middle income | 4,310 | 280 | 1.34 |
| Lower middle income | 1,364 | 77 | 4.87 |
| Low income | 753 | 29 | 12.93 |
*Data obtained from World Health Organization website (www.who.int/nha). GNP, gross national product.
†In US$.
